tiprankstipranks
Coloplast A/S (GB:0QBO)
:0QBO
UK Market

Coloplast A/S (0QBO) Financial Statements

Compare
25 Followers

Coloplast A/S Financial Overview

Coloplast A/S's market cap is currently kr171.90B. The company's EPS TTM is kr21.713; its P/E ratio is 35.19; and it has a dividend yield of 2.87%. Coloplast A/S is scheduled to report earnings on February 4, 2025, and the estimated EPS forecast is kr5.39. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Sep 22Sep 21Sep 20Sep 19
Income Statement
Total Revenue
Gross Profit-$ 15.53B$ 13.31B$ 12.61B$ 12.15B
Operating Income
EBITDA$ 7.73B$ 7.23B$ 7.05B$ 6.35B$ 5.68B
Net Income
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets
Total Debt$ 0.00$ 18.71B$ 2.79B$ 1.75B$ 1.21B
Net Debt$ 0.00$ 18.07B$ 2.11B$ 1.16B$ 539.00M
Total Liabilities
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Currency in USD

Coloplast A/S Earnings and Revenue History

Coloplast A/S Debt to Assets

Coloplast A/S Cash Flow

Coloplast A/S Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis